104436-60-4 Usage
General Description
4-CYANO-2-METHOXYBENZYL BROMIDE is a chemical compound with the molecular formula C9H8BrNO. It is a benzyl bromide derivative with a cyano group and a methoxy group attached to the benzene ring. 4-CYANO-2-METHOXYBENZYL BROMIDE is commonly used in organic synthesis as a versatile intermediate for the preparation of various pharmaceuticals and agrochemicals. It is also used as a reagent for the synthesis of other organic compounds due to its ability to undergo substitution and elimination reactions. Additionally, it is known to have potential biological activity and has been studied for its pharmacological properties. Overall, 4-CYANO-2-METHOXYBENZYL BROMIDE is a valuable compound in the field of organic chemistry with numerous applications in the pharmaceutical and agrochemical industries.
Check Digit Verification of cas no
The CAS Registry Mumber 104436-60-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,4,4,3 and 6 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 104436-60:
(8*1)+(7*0)+(6*4)+(5*4)+(4*3)+(3*6)+(2*6)+(1*0)=94
94 % 10 = 4
So 104436-60-4 is a valid CAS Registry Number.
104436-60-4Relevant articles and documents
ESTROGEN-RELATED RECEPTOR ALPHA (ERRα) MODULATORS
-
Page/Page column 59, (2021/01/23)
The present invention is directed to compounds according to Formula (I) and the pharmaceutically acceptable salts thereof. The compounds can be used as modulators of Estrogen-related Receptor alpha (ERRα) and have utility in the treatment of ERRα-mediated
Synthesis method of 2-methoxyl-4-cyanobenzaldehyde
-
, (2018/04/03)
The invention discloses a synthesis method of 2-methoxyl-4-cyanobenzaldehyde. The method comprises the following steps: 1, carrying out acylating chlorination on 4-methyl-3-methoxybenzoic acid servingas a raw material, and then carrying out aminolysis to
ALDOSTERONE SYNTHASE AND/OR 11β-HYDROXYLASE INHIBITORS
-
, (2008/06/13)
The present invention provides a compound of formula (I). Said compound is inhibitor of CYP11B2 and/or CYP11B1, and thus can be employed for the treatment of a disorder or disease mediated by CYP11B2 and/or CYP11B1.